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Introduction
Nitrofuran antibiotics including furazolidone, furaltadone, nitrofurazone and nitrofurantoin are a class of synthetic broad spectrum antibiotics which have been widely used both prophylactically and therapeutically for various bacterial and protozoan infections in fish, prawn, bees, swine, cattle and poultry [1] . However, since the early 1990s, various experimental animal studies have shown that nitrofurans and their metabolites have potential mutagenicity and genotoxicity [2] . As a consequence, nitrofurans have been banned for use in animal husbandry in the European Union (EU) and other countries [2] . The EU has set the minimum required performance limits (MRPLs) to be 1 μg kg -1 for each nitrofuran metabolite in food of animal origin [3] . Nonetheless, the illegal use of nitrofuran still exists in many countries, particularly developing countries, mainly due to their effectiveness and low cost. Therefore, monitoring programs are deemed necessary to prevent the consumption of potentially harmful nitrofuran antibiotic residues in food.
Nitrofuran antibiotics are rapidly metabolized in vivo and do not persist as residues of the parent drugs in edible tissues [4] . Their metabolites can bind to tissue proteins and may persist for considerable periods of time in animal tissues. Therefore, the analytical detection of furaltadone, furazolidone, nitrofurazone and nitrofurantoin can be monitored through the measurement of their metabolites, 3-amino-5-methylmorpholino-2-oxazolidinone (AMOZ) 3-amino-2oxazolidinone (AOZ), semicarbazide (SEM) and 1-aminohydantoin (AHD), respectively [5] . Instrumental analytical methods such as liquid chromatography with ultraviolet (UV) or UV photodiode array detection and the coupling of high performance liquid chromatography and liquid chromatography electro-spray ionisation to tandem mass spectrometry (HPLC-MS/MS and LC-ESI MS/MS, respectively) are well established for the determination of nitrofuran antibiotics and their metabolites. A detailed review on the residual analysis of nitrofurans and their metabolites was recently published by Vass et al. [2] . The instrumental methods can offer high sensitivity and specificity and have the potential for simultaneous determination of several nitrofurans, but the associated highcosts, time-consuming labour requirements and practicalities of the instrumentation have inhibited broadening the scope of monitoring particularly to field-screening scenarios. As an alternative, immunoassays based on the interaction of antibody and antigen provide a low cost, portable and high throughput screening method capable of the sensitive determination of nitrofuran metabolites. The first enzyme-linked immunosorbent assay (ELISA) capable of detecting the furazolidone metabolite (AOZ) was developed by Cooper et al. [6] under the support of a multi-national EU research project "FoodBRAND" [2] . Since then, immunoassays for the determination of AOZ [7] [8] [9] , SEM [10] [11] [12] , AHD [13, 14] and AMOZ [15] were reported in succession.
As the nitrofuran metabolites are relatively small molecular weight compounds, there always exists great difficulty in producing antibodies directly which are specific to the metabolites. As nitrofuran metabolites are covalently bound to proteins and are released from the tissues under slightly acidic conditions, they are derivatised with onitrobenzaldehyde (o-NBA) to form nitrophenyl (NP) derivatives prior to detection [16] .
Therefore, immunoassays for nitrofuran metabolites are developed based on antibodies specific to their NP derivatives (e.g. NPAOZ, NASEM, NPAHD and NPAMOZ) [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . In most studies, nitrofuran metabolites were derivatised with 3-carboxybenzaldehyle (3-CBA) or 4-carboxybenzaldehyle (4-CBA) to form immunizing haptens [6, 7, [9] [10] [11] [12] [13] [14] [15] . The haptens were coupled to carrier proteins through the carboxylic acid spacer to generate immunogens.
However, in relation to hapten design for small molecular weight compounds, a suitable length of spacer between the hapten and the carrier protein should be beneficial for producing desired antibodies [17] . A previous study indicated that the conformation of a hapten could be altered when too short a spacer is employed for its conjugation to the carrier protein [18] .
Therefore, a question posed in this study was to determine whether it was possible to improve the assay sensitivity for nitrofuran metabolites by introducing a certain length of spacer between the phenyl ring and the carrier protein using the furaltadone metabolite AMOZ as the metabolite model. The first objective was to form two novel immunizing haptens, which contained a methoxyacetic acid spacer ( Fig. 1 ) by derivatising AMOZ using 2-(4-formylphenoxy)acetic acid or 2-(3-formylphenoxy)acetic acid. Secondly, the ability of these novel haptens for producing specific antibodies against NPAMOZ was to be evaluated and compared with the traditional immunizing haptens, derivatised AMOZ with 3-CBA and 4-CBA ( Fig. 1) . Molecular modeling will be applied to obtain the lowest energy conformation of the target molecule and haptens to elucidate the results of ciELISA when each of the different antibodies raised to the various haptens are utilized. A further aim was to evaluate the effect of different combinations of heterologous assay format on assay sensitivity using each of the synthesized haptens and an additional novel hapten synthesized by derivatising AMOZ with 2-oxoacetic acid which provides a short spacer between the hapten and protein.
Finally, the ELISA method for determination of AMOZ was developed and applied to fish and shrimp samples, and the results were validated by standard LC-MS/MS method.
Experimental

Materials and reagents
Furaltadone, AMOZ, NPAMOZ, 4-CBA, 3-CBA, 2-(4-formylphenoxy)acetic acid, 2-(3- Ltd., China) on glass sheets. Polystyrene ELISA plates were obtained from Jiete Biotech Co., Ltd (Guangzhou, China). All other chemicals and organic solvents were of analytical grades.
Instrumentation
Ultraviolet-visible (UV-Vis) spectra were recorded on a UV-160A Shimadzu spectrophotometer (Kyoto, Japan). ESI-MS analysis for haptens was performed using an Agilent HP1100 series (Agilent, Palo Alto, CA). Nuclear magnetic resonance (NMR) spectra were obtained with both the DRX-400 and DRX-600 NMR spectrometers (Bruker, GermanySwitzerland). LC-MS/MS analysis for AMOZ was carried out by using the 1200 series LC system (Agilent Technologies, USA) equipped with the Agilent 6410 Triple Quad LC-MS System (Agilent Technologies, USA). ELISA plates were washed using Multiskan MK2 microplate washer (Thermo Labsystems, USA). Absorbance was measured at 450 nm of wavelength using Multiskan MK3 microplate reader (Thermo Labsystems, USA).
Buffers and solutions
The buffers used in this study were as follows: 0. 
Synthesis and characterization of haptens
Five haptens ( 
Preparation of hapten-protein conjugates
Four haptens (Hapten1 to Hapten4) were coupled to BSA for immunogens and all five haptens were coupled to OVA for coating antigens. Hapten (10 μmol), NHS (20 μmol) and DCC (20 μmol) were dissolved in 500 μL of DMF. The mixture was stirred gently at 4 ºC overnight, and then centrifuged at 2500 g for 10 min. The supernatant (about 400 μL) was added dropwise to BSA (90 mg) or OVA (60 mg) in 9.5 mL PBS (pH7.4). The conjugation mixture was then stirred at 4 ºC for 12 hours and then purified on Sephadex G-25, using 0.01mol L -1 of NaHCO 3 as the eluent. The eluted conjugates were dialyzed against PBS (pH 7.4) and then freeze-dried before storage at 4 ºC. Full wavelength (200-500 nm) UV-Vis scanning was used to confirm the structures of the final conjugates and the ratios of haptens to carrier proteins were determined by trinitro-benzene-sulfonic acid (TNBS) method [19] .
Production of polyclonal antibodies
Immunogens were dissolved in 0.01 mol L -1 PBS (1.0 mL) and emulsified with 1.0 mL of were left to coagulate for 1.0 h at room temperature and overnight at 4 ºC, and then centrifuged at 10,000 g for 10 min. The antisera (supernatant) were carefully collected, divide into aliquots and stored at -20 ºC until used.
Titration of antisera
The affinity of each antiserum was determined by non-competitive indirect ELISA. ), and the absorbance was recorded at 450 nm.
Competitive indirect ELISA (ciELISA)
The effect of the different spacer arms of the immunizing haptens on the properties of the antibodies and the heterology of coating antigens on ELISA sensitivity was investigated by competitive indirect ELISA (ciELISA). The checkerboard procedure was used to optimize the coating antigen and the antibody concentrations. For the ELISA, each well of a microtitre plate was coated with 100 µL of the coating antigen at the optimal dilution in carbonate buffer overnight at 4 ºC. After washing 5 times with PBST solution, the excess binding sites were blocked with 5% glycine and 5% sucrose in PBS buffer (200 µL well ), and the absorbance was recorded at analyte concentration. The sigmoid curves were generated by using OriginPro 7.5 software (OriginLab Corp., Northampton, MA, USA). The limit of detection (LOD) was defined as the concentration of analyte that produced a reduction of 10% of the maximum normalized response (IC 10 ). The linear range was defined as the lower and upper limits of quantification, which refers to the IC 20 -IC 80 linear range.
Molecular modeling
The structures of NPAMOZ and the haptens were initially drawn in HyperChem 7.0 software (Hypercube, Inc., USA). The most stable conformations were optimized using
Hartree-Fock (HF) with a 6-31G* basis set in the Gaussian 03 package (revision B.05, Gaussian, Inc., USA). The alignment of haptens and NPAMOZ was completed by SYBYL7.3
program package (Tripos, Inc., USA) on a personal computer.
Samples analysis
For the determination of nitrofuran metabolites in animal tissue samples, the first step of the procedure, which was always carried out under mildly acidic conditions, was the release of bound metabolites from the tissue. Next, the derivatisation of metabolites using o-NBA was necessary in order to increase the molecular mass and to improve the sensitivity of detection. The extraction of the nitrophenyl derivatives was carried out using a moderately polar organic solvent such as ethyl acetate, and a clean up step using a non polar solvent such as hexane was used to remove lipids from the sample prior to detection. acetate layer (2.5 mL) was transferred into another glass tube and dried using nitrogen gas at 55 ºC. Hexane (0.5 mL) was added to the tube and vortexed thoroughly followed by the addition of 0.5 mL of PBS. After vortexing again, the sample was centrifuged (3,000 × g) at room temperature for 10 min. The upper hexane layer was removed and the remaining extract was used for analysis.
For ELISA analysis, the extract was diluted three times with the PBS assay buffer. For LC-MS/MS analysis, the extract was filtered with a microporous membrane (0.45 μm) prior to
use. An Agilent ZORBAX SB-C 18 (2.1×150 mm, 3.5 µm particle size) column was used.
Mobile phase A consisted of 0.1% formic acid in water and mobile phase B was acetonitrile.
The following gradient profile: 0 min, 22% B; 0-6 min, 22-99% B; 6-9 min, 99%B; 9-9.1 min, 99-22% B; 9.1-15 min, 22% B. The flow rate of the mobile phase was 0.3 mL min -1 and an aliquot of 5 µL of each sample was injected into the LC system. Analytes were determined by ESI-MS/MS in positive mode. The parameters were as follows: gas temperature, 350 °C; gas flow, 10 L min -1 ; nebulizer gas, 35 psi; capillary voltage, 4.0 kV. High-purity nitrogen (>99.99%) was served as the nebulizer and collision gas.
Results and discussion
Design and synthesis of haptens
Hapten design and synthesis plays a key role in the development of immunoassays for small molecular weight compounds [21] . For nitrofuran metabolites, haptens were always designed by derivatising the metabolites with 3-CBA or 4-CBA [6, 7, [9] [10] [11] [12] [13] [14] [15] . Although this strategy was able to generate antibodies with high specificity and sensitivity, it's believed that there are some other strategies to further improve the antibody characteristics. Cheng et al. [8] tried to introduce a 6-methoxyhexanoic acid spacer on the 5' position of phenyl ring of NPAOZ and used it as a new immunizing hapten. This hapten possessed the -NO 2 group and therefore the corresponding antibody showed higher sensitivity and specificity against NPAOZ in ELISA, compared with the antibody generated with CPAMOZ [6] [7] [8] . However, the hapten was difficult to synthesize. In this work, four benzaldehyde derivatives (including 4-CBA (hapten 1, containing 1 carbon spacer), 3-CBA (hapten 2, containing 1 carbon spacer), 2-(4-formylphenoxy)acetic acid (hapten 3, containing 2 carbon and 1 oxygen spacer), and 2-(3-formylphenoxy)acetic acid (hapten 4, containing 2 carbon and 1 oxygen spacer)) were attached to AMOZ for immunizing haptens to study the effect of spacer group on production of specific antibodies against the NPAMOZ. Moreover, another hapten consisting of AMOZ moiety and a simple carboxyl spacer was synthesized as a coating hapten, because previous studies had revealed that using only a partial structure of the target molecule as the coating hapten may be a good strategy to improve assay sensitivity [22, 23] .
The synthesis of each of the five haptens can be achieved for each using a one step reaction. The synthesized haptens were characterized by ESI-MS and NMR and the data generated is presented, as shown in the previous experimental section 1. This data suggested that the synthesis of all five target haptens ( Fig. 1 ) was successful. respectively. The binding ratios of immunogens were suggested to be suitable to evoke a specific immune response [24] .
Preparation of hapten-protein conjugates
Antisera titer
Eight white New Zealand rabbits were used to prepare polyclonal antisera against four immunogens. All the rabbits' antisera exhibited high levels of polyclonal antibodies; the titer values after the 3 rd injection were 0.84-1.32 at 1: 60,000 dilutions in homologous indirect ELISA. Antiserum R215, R217, R220 and R221 that showed higher titers in indirect ELISA and better sensitivity in ciELISA were used in subsequent studies.
Characterization of polyclonal antibodies
To study the effects of the immunizing haptens and heterologous coating on assay sensitivity, ciELISA based on different antiserum (R215, R217, R220 and R221, respectively) and different coating (hapten 1-OVA, hapten 2-OVA, hapten 3-OVA, hapten 4-OVA and hapten 5-OVA, respectively) were developed. The IC 50 values for NPAMOZ are displayed in Table 1 .
Effect of immunizing haptens
As shown in Table 1 However, antibodies R220 and R221 showed improved sensitivity for NPAMOZ in ciELISA in comparison with antibodies R215 and R217, which indicated that the length of spacer on the phenyl ring of immunizing haptens did significantly influence the sensitivity of antibody in ciELISA. Those antibodies raised to haptens 3 and 4 incorporating the phenoxy group displayed almost a 2 fold increase in sensitivity.
It is well known that the three dimensional structure is important for the antibody recognition of low molecular weight haptenic compounds [25] . The introduction of a linker or spacer arm between the hapten and carrier protein may cause perturbations in the threedimensional conformation of the hapten [26] . Therefore, the lowest energy conformations were calculated for the free haptens and NPAMOZ in this study. Based on these stable conformations, each immunizing hapten was matched with NPAMOZ and the results are shown in Fig. 2 . Clearly, the part of the AMOZ structure of hapten 3 and hapten 4 were well matched with that of NPAMOZ (Fig. 2, C and D) . However, this matching was not obtained in the alignment of hapten 1 and hapten 2 with NPAMOZ. An obvious conformational change was observed at the structure of morpholine ring for both hapten 1 and hapten 2 (Fig. 2, A and B). The introduction of a carboxyl group on the phenyl ring might influence the electronic distribution of phenyl ring and then further influence the conformation of AMOZ structure. While introducing a spacer between the carboxyl group and the phenyl ring, this influence may decrease. Therefore, the introduction of a certain length of spacer between the carboxyl group and the phenyl ring is important for producing an antibody with improved sensitivity for NPAMOZ.
Effect of heterologous assay format
It's generally accepted that heterology usually results in weaker recognition of antibody to the ELISA plate-coating antigen compared to the recognition of the target analyte. Thus, lower analyte concentrations can compete with these reagents, which results in improved assay sensitivity [27, 28] . However, the design of an optimal heterologous coating hapten is not so easy. As shown in Table 1 , for each antibody, the heterologous coating can improve the assay sensitivity, but not all the improvements are noteworthy. For examples, for antibody R215, when using hapten 2-OVA, hapten 3-OVA and hapten 4-OVA, the assay sensitivity was not improved significantly. This might be due to the low degree of hapten heterology. However, the assay sensitivity for all four antibodies was greatly improved when using hapten 5-OVA as the coating antigen. A 2 to 3 fold increase in sensitivity was obtained for all four antibodies when hapten 5-OVA was used as the coating antigen. Hapten 5 exhibited the AMOZ moiety, which was a partial structure of the target molecule (NPAMOZ).
The result of this study demonstrated a previous conclusion that using only a partial structure of the target molecule as the coating hapten may be a good strategy to improve assay sensitivity [22, 23] .
Optimization of ELISA conditions
With the aim to improve the ciELISA performance the influence of several factors (pH, ionic strength and Tween-20 concentration) ciELISA were examined. For each condition, the standard curves for NPAMOZ were established (n=3) and the maximum absorbance value (B 0 ) as well as the concentration of analyte that produces a 50% decrease in B 0 (IC 50 ) were obtained. The B 0 /IC 50 ratio was used to estimate the effect of a certain factor on the ciELISA performance, the higher ratio indicating the higher sensitivity response to the condition being tested [29, 30] . As shown in Fig. 3A , both the absorbance value and the sensitivity increased first and then decreased with pH values ranging from 5.0 to 9.0. The highest B 0 /IC 50 value was obtained when the pH value was around 7.0. Therefore, it was chosen as the optimal pH of the buffer. For ionic strength, with the increasing concentration of salt, the absorbance value increased gradually and reached a peak at 40 mmol L -1 , and then decreased (Fig. 3B) , which indicated that a high salt concentration might inhibit the antibody-antigen interaction. The salt concentration at 20 mmol L -1 appeared to be the optimal condition for the competition buffer since the highest value of B 0 /IC 50 was obtained.
Tween-20 is a nonionic surfactant commonly used in immunoassay protocols to reduce nonspecific interactions [30] . In this work, the effect of Tween-20 concentration on ELISA performance was also studied. As shown in Fig. 3C , low content of Tween-20 in the assay buffer was advantageous for the antibody-antigen interaction and the competition of analyte. The presence of 0.01% Tween-20 in the assay buffer provided the best assay sensitivity.
As a result of the immunoassay evaluation described above we can conclude that some Until now, only one other publication described and reported the development of an ELISA for AMOZ [15] . In that research, AMOZ was derivatised with 3-CBA and used as an immunizing hapten. The IC 50 value for NPAMOZ ranged from 1.59-72.3 μg L -1 in the homologous ciELISA was based on different monoclonal antibodies. Our results indicated that by using the new immunizing hapten (hapten 4) and the heterologous coating system, the assay sensitivity for NPAMOZ was improved. In our lab, the research is now focusing on the screening of hybridomas that secrete monoclonal antibodies against NPAMOZ (based on the novel immunogen, hapten 4-BSA). It is envisaged that the production of monoclonal antibodies with higher sensitivity to NPAMOZ can be achieved.
Antibody specificity
Nitrofuran drugs and their metabolites, the nitrophenyl derivatives of metabolites, and several other veterinary drugs commonly used in fishery were used to test the specificity of antibody R221. Table 2 From the three dimensional structure of NPAMOZ, the morpholine ring derivative formed a big crook with the moiety of 3-aminooxazolidin-2-one, which should be for antibody binding.
A similar result was also obtained in the research by Pimpitak et al. [15] . The antibody also showed no cross-reactivity to various veterinary drugs or the derivatising agent o-NBA. It is well known that nitrofuran drugs are metabolized rapidly in vivo, and as a consequence the significant cross-reactivity with furaltadone is unlikely to affect the determined results in practice. The negligible assay response to o-NBA (<0.02%) eliminates the need for separation of this reagent from the sample homogenate after derivatisation when employing published extraction procedures [12] . )] × 100.
Analysis of samples
Conclusions
Table 3
Recoveries 
